XTENLAS Trademark

Trademark Overview

On Wednesday, January 4, 2017, a trademark application was filed for XTENLAS with the United States Patent and Trademark Office. The USPTO has given the XTENLAS trademark a serial number of 87289419. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2019. This trademark is owned by Pfenex Inc.. The XTENLAS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production
xtenlas

General Information

Serial Number87289419
Word MarkXTENLAS
Filing DateWednesday, January 4, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 12, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfenex Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePfenex Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 5, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 5, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 19, 2018EXTENSION 3 GRANTED
Monday, November 19, 2018EXTENSION 3 FILED
Monday, November 19, 2018TEAS EXTENSION RECEIVED
Saturday, June 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 21, 2018EXTENSION 2 GRANTED
Thursday, June 21, 2018EXTENSION 2 FILED
Thursday, June 21, 2018TEAS EXTENSION RECEIVED
Wednesday, January 10, 2018ITU LETTER MAILED, NO RESPONSE REQUIRED
Wednesday, January 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2018TEAS EXTENSION RECEIVED
Wednesday, January 3, 2018EXTENSION 1 GRANTED
Wednesday, January 3, 2018EXTENSION 1 FILED
Wednesday, January 3, 2018TEAS EXTENSION RECEIVED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2017ASSIGNED TO EXAMINER
Thursday, January 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 7, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

xtenlas white blood cell production stimulating used preparations namely pharmaceuticals pharmaceutical